Pharming buys rare disease drug from Novartis for $20mPharming has bought a late-stage pipeline drug aimed at a rare disease of the immune system from Novartis Share XPharming buys rare disease drug from Novartis for $20mhttps://pharmaphorum.com/news/pharming-buys-rare-disease-drug-from-novartis-for-20m/
NHS patients to receive digital diabetes prevention supportThousands of patients at risk of type 2 diabetes are to receive digital support to help prevent them Share XNHS patients to receive digital diabetes prevention supporthttps://pharmaphorum.com/news/nhs-patients-to-receive-digital-diabetes-support/
AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatmentAstraZeneca and MSD’s Lynparza has scored its second Phase 3 win in the space of a week, this Share XAZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatmenthttps://pharmaphorum.com/news/az-msd-parp-inhibitor-ovarian-cancer/
McCann Health promotes Hilary Gentile to global chief strategy officerMcCann Health has promoted Hilary Gentile to the newly created position of global chief strategy officer. Hilary has Share XMcCann Health promotes Hilary Gentile to global chief strategy officerhttps://pharmaphorum.com/news/mccann-health-promotes-hilary-gentile-to-global-chief-strategy-officer/
First effective Ebola treatment a step closer after breakthrough trialClinical trials of four experimental treatments for Ebola in the Congo have been halted early after two of Share XFirst effective Ebola treatment a step closer after breakthrough trialhttps://pharmaphorum.com/news/ebola-virus-clinical-trial-breakthrough/
LIVI expands reach for its NHS GP consultation mobile appDigital healthcare firm LIVI has signed new agreements with the NHS that will open up access to its Share XLIVI expands reach for its NHS GP consultation mobile apphttps://pharmaphorum.com/news/nhs-gp-consultation-app-expanded/
GSK announces US leadership changesGlaxoSmithKline has poached Merck KGaA’s Maya Martinez-Davis to head up its US Pharmaceuticals division as it announces current Share XGSK announces US leadership changeshttps://pharmaphorum.com/news/gsk-announces-us-leadership-changes/
US senators blast Novartis for Zolgensma data falsificationUS politicians have urged the FDA to come down hard on Novartis for failing to disclose manipulated data Share XUS senators blast Novartis for Zolgensma data falsificationhttps://pharmaphorum.com/news/us-senators-blast-novartis-for-zolgensma-data-falsification/
Boehringer jumps on KRAS cancer drug bandwagon with MD AndersonBoehringer Ingelheim has become the latest pharma company to investigate KRAS as a potential target for cancer drugs, Share XBoehringer jumps on KRAS cancer drug bandwagon with MD Andersonhttps://pharmaphorum.com/news/boehringer-jumps-on-kras-cancer-drug-bandwagon-with-md-anderson/
